HK1194302A1 - 紫檀茋在製造用於治療、緩解或預防焦慮的藥物組合物中的應用 - Google Patents
紫檀茋在製造用於治療、緩解或預防焦慮的藥物組合物中的應用Info
- Publication number
- HK1194302A1 HK1194302A1 HK14107876.8A HK14107876A HK1194302A1 HK 1194302 A1 HK1194302 A1 HK 1194302A1 HK 14107876 A HK14107876 A HK 14107876A HK 1194302 A1 HK1194302 A1 HK 1194302A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pterostilbene
- alleviation
- anxiety
- prevention
- manufacture
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title 1
- 230000036506 anxiety Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- VLEUZFDZJKSGMX-ONEGZZNKSA-N pterostilbene Chemical compound COC1=CC(OC)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-ONEGZZNKSA-N 0.000 title 1
- VLEUZFDZJKSGMX-UHFFFAOYSA-N pterostilbene Natural products COC1=CC(OC)=CC(C=CC=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/105,470 US9439875B2 (en) | 2011-05-11 | 2011-05-11 | Anxiolytic effect of pterostilbene |
| PCT/US2012/037325 WO2012154956A2 (en) | 2011-05-11 | 2012-05-10 | Anxiolytic effect of pterostilbene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1194302A1 true HK1194302A1 (zh) | 2014-10-17 |
Family
ID=47140003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14107876.8A HK1194302A1 (zh) | 2011-05-11 | 2014-08-01 | 紫檀茋在製造用於治療、緩解或預防焦慮的藥物組合物中的應用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9439875B2 (zh) |
| EP (1) | EP2706992B1 (zh) |
| JP (2) | JP6027607B2 (zh) |
| KR (1) | KR101929074B1 (zh) |
| CN (1) | CN103561729B (zh) |
| AU (1) | AU2012253479B2 (zh) |
| BR (1) | BR112013028776B1 (zh) |
| CA (1) | CA2839309C (zh) |
| HK (1) | HK1194302A1 (zh) |
| WO (1) | WO2012154956A2 (zh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9439875B2 (en) * | 2011-05-11 | 2016-09-13 | The United States Of America, As Represented By The Secretary Of Agriculture | Anxiolytic effect of pterostilbene |
| EP2968368B1 (en) | 2013-03-15 | 2017-08-09 | Glia LLC | Cranial delivery of pharmaceuticals |
| CN103333141B (zh) * | 2013-06-05 | 2015-04-29 | 宁波大学 | 一种白藜芦醇低聚茋类化合物及其制备方法和应用 |
| JP6406865B2 (ja) * | 2014-04-25 | 2018-10-17 | 森永製菓株式会社 | 濃度測定方法 |
| JP6463956B2 (ja) * | 2014-11-28 | 2019-02-06 | キユーピー株式会社 | 乳化組成物及びその製造方法 |
| CN104706627A (zh) * | 2015-03-12 | 2015-06-17 | 厦门大学 | 一种治疗缺血性脑中风的药物 |
| WO2017011318A1 (en) | 2015-07-10 | 2017-01-19 | University Of Miami | Methods for treating mucopolysaccharidosis |
| AU2017316614B2 (en) | 2016-08-22 | 2023-06-15 | Elysium Health, Inc. | Nicotinamide riboside and pterostilbene compositions and methods for treatment of neurodegenerative disorders |
| US20200085849A1 (en) * | 2017-05-18 | 2020-03-19 | Elysium Health, Inc. | Methods and compositions for improving sleep |
| JP6619108B2 (ja) * | 2019-01-07 | 2019-12-11 | キユーピー株式会社 | 乳化組成物及びその製造方法 |
| CN111569084B (zh) * | 2019-02-19 | 2021-07-13 | 中国科学院上海药物研究所 | 基于柳胺酚和紫檀芪的成环偶联分子dcz0801类化合物、其制备方法及用途 |
| CN110075094A (zh) * | 2019-02-27 | 2019-08-02 | 延边大学 | 紫檀芪在制备药物或保健品中的应用 |
| CN112618520A (zh) * | 2021-01-14 | 2021-04-09 | 姚大纯 | 紫檀芪或白藜芦醇在制备用于治疗或改善孤独症谱系障碍的药物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060057231A1 (en) * | 2004-08-19 | 2006-03-16 | Rimando Agnes M | Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform |
| TW200640529A (en) * | 2005-02-28 | 2006-12-01 | Thomas Christian Lines | Composition for treating mental health disorders |
| US20080108574A1 (en) * | 2006-09-27 | 2008-05-08 | Braincells, Inc. | Melanocortin receptor mediated modulation of neurogenesis |
| US20090069444A1 (en) * | 2007-09-07 | 2009-03-12 | The United States Of America, As Represented By Th E Secretary Of Agriculture | Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration |
| US20090163580A1 (en) * | 2007-12-24 | 2009-06-25 | Natrol, Inc. | Anti-aging composition containing resveratrol and method of administration |
| JP5526762B2 (ja) * | 2009-02-17 | 2014-06-18 | Ｊｎｃ株式会社 | 誘電率異方性が負の液晶性化合物、これを用いた液晶組成物および液晶表示素子 |
| WO2010095926A1 (en) * | 2009-02-20 | 2010-08-26 | N.V. Nutricia | Use of reveratrol for preserving cognitive functioning |
| US9737495B2 (en) * | 2009-06-22 | 2017-08-22 | Indus Biotech Private Limited | Process for obtaining purified pterostilbene and methods of use thereof |
| EP2322159A1 (en) * | 2009-10-30 | 2011-05-18 | Green Molecular, S.L. | Use of pterostilbene (pter) as medicament for prevention and/or treatment of skin diseases, damages or injures or as cosmetic |
| US9439875B2 (en) * | 2011-05-11 | 2016-09-13 | The United States Of America, As Represented By The Secretary Of Agriculture | Anxiolytic effect of pterostilbene |
-
2011
- 2011-05-11 US US13/105,470 patent/US9439875B2/en not_active Expired - Fee Related
-
2012
- 2012-05-10 CA CA2839309A patent/CA2839309C/en active Active
- 2012-05-10 BR BR112013028776-4A patent/BR112013028776B1/pt active IP Right Grant
- 2012-05-10 KR KR1020137032950A patent/KR101929074B1/ko active IP Right Grant
- 2012-05-10 AU AU2012253479A patent/AU2012253479B2/en active Active
- 2012-05-10 CN CN201280022178.5A patent/CN103561729B/zh active Active
- 2012-05-10 JP JP2014510467A patent/JP6027607B2/ja active Active
- 2012-05-10 WO PCT/US2012/037325 patent/WO2012154956A2/en active Application Filing
- 2012-05-10 EP EP12781700.5A patent/EP2706992B1/en active Active
-
2014
- 2014-08-01 HK HK14107876.8A patent/HK1194302A1/zh unknown
-
2016
- 2016-10-14 JP JP2016202351A patent/JP2017014284A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2706992A2 (en) | 2014-03-19 |
| BR112013028776A2 (pt) | 2017-01-24 |
| CA2839309C (en) | 2019-05-07 |
| US20160067192A1 (en) | 2016-03-10 |
| AU2012253479B2 (en) | 2016-12-22 |
| CN103561729A (zh) | 2014-02-05 |
| EP2706992A4 (en) | 2014-12-17 |
| CN103561729B (zh) | 2016-03-09 |
| BR112013028776B1 (pt) | 2022-04-19 |
| AU2012253479A1 (en) | 2013-11-28 |
| JP2017014284A (ja) | 2017-01-19 |
| WO2012154956A2 (en) | 2012-11-15 |
| US9439875B2 (en) | 2016-09-13 |
| CA2839309A1 (en) | 2012-11-15 |
| KR20140107112A (ko) | 2014-09-04 |
| EP2706992B1 (en) | 2019-09-04 |
| JP6027607B2 (ja) | 2016-11-16 |
| KR101929074B1 (ko) | 2018-12-13 |
| WO2012154956A3 (en) | 2013-01-24 |
| JP2014514361A (ja) | 2014-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1194302A1 (zh) | 紫檀茋在製造用於治療、緩解或預防焦慮的藥物組合物中的應用 | |
| HK1196131A1 (zh) | 用於治療或預防呼吸道合胞病毒疾病的化合物 | |
| HK1197400A1 (zh) | 治療 的化合物 | |
| ZA201403795B (en) | Formulations for the treatment of diabetes | |
| SG11201400580VA (en) | Pharmaceutical composition for inhalation | |
| AP2014007399A0 (en) | Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament | |
| HK1184370A1 (zh) | 用於治療疼痛的藥物組合 | |
| IL222890A0 (en) | Medicaments for the treatment of il-1beta related conditions | |
| HK1206938A1 (zh) | -氯- -三氟-吡啶甲腈的製備方法 | |
| EP2769718A4 (en) | MEDICINAL COMPOSITION | |
| HK1197058A1 (zh) | 用於治療或預防呼吸道合胞病毒疾病的化合物 | |
| HRP20181761T1 (hr) | Novi pripravak alfentanila za liječenje akutne boli | |
| HK1197235A1 (zh) | 二氫吡唑、其藥物組合物及其治療生育障礙的用途 | |
| IL234796B (en) | Compounds for the treatment of diseases related to ischemia-reperfusion | |
| HK1206729A1 (zh) | 作爲 拮抗劑用於治療呼吸系統疾病的 -雜芳基- -三氟甲基-丙基 -哌啶- -基或-嗎啉- -基化合物 | |
| IL238071B (en) | Pharmaceutical composition of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof for the treatment of cardiovascular disease | |
| HK1186104A1 (zh) | 牛蒡子苷元在製備治療或預防腦膠質瘤藥物中的用途 | |
| EP2785342A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERTRIGLYCERIDEMIA OR DISEASES ASSOCIATED WITH HYPERTRIGLYCERIDEMIA | |
| HUP1100534A2 (en) | Pharmaceutical composition for the treatment of muscle atrophy | |
| HUP1100245A2 (en) | Pharmaceutical composition for the treatment of wounds | |
| ZA201400442B (en) | Compounds for the treatment and prophylaxis of respiratory syncytial virus disease | |
| HK1196953A1 (zh) | 用於治療糖尿病的製劑 | |
| PL2812351T3 (pl) | Kompozycja farmaceutyczna do leczenia stwardnienia rozsianego |